Innovent and Lilly sign Verzenios China deal
Innovent Biologics and Lilly (NYSE:LLY) entered a commercialization agreement for Verzenios (abemaciclib) in mainland China, shifting commercial control to Innovent.
Innovent Biologics and Lilly (NYSE:LLY) entered a commercialization agreement for Verzenios (abemaciclib) in mainland China, shifting commercial control to Innovent.
Fabiana Fedeli, CIO of multi-asset at M&G Investments, says that while there is still value in equities, markets such as South Korea have displayed "exuberant" behavior. Speaking on Bloomberg Television, she says: "there is a whole host of stocks which are the AI losers the stocks that have been forgotten by the AI trade that I still think I still think are very worthwhile investing in."
Hafnia (NYSE:HAFN) said Chief Executive Officer Mikael Skov will step down on 1 September 2026, with EVP Søren Steenberg Jensen appointed as his successor.
Evotec (NASDAQ:EVO) launched J.TRAIN, a turnkey biologics manufacturing model designed to place its continuous manufacturing technology inside partner-owned facilities.
Iran's deputy foreign minister says they remain firm on maintaining control over maritime traffic in the Strait of Hormuz, ahead of fresh negotiations with the US on ending the war. Victoria Mitchell, Senior Analyst at Control Risks spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East and Africa about the tolling of the waterway.
India's IPO market is expected to rebound after a muted first half, with stronger fundraising driven by a robust pipeline and improving valuations. Large deal filings, resilient domestic inflows, and positive post-listing returns are supporting momentum, despite risks from inflation, geopolitics and even the weather. V Jayasankar, Managing Director & Deputy CEO at Kotak Investment Banking, joined Haslinda Amin on Insight with Haslinda Amin to discuss the outlook and key drivers for India's equity markets.
A top Iranian official has reiterated Tehran's determination to maintain control over maritime traffic moving through the Strait of Hormuz, raising the stakes ahead of fresh negotiations with the US. Bloomberg's Abeer Abu Omar reports from Dubai.
Cal-Maine Foods (NASDAQ:CALM) said it has reached an agreement to resolve claims brought by the U.S. Department of Justice and 17 state attorneys general following a 15-month investigation into egg pricing practices.
Georges Kern, CEO of House of Brands, says that although the group is gaining market share in China, consumers remain reluctant to invest in luxury goods. He also shares more about the group's expansion plans on "Bloomberg: The China Show."
Tom Bartlebaugh, CEO of Miniso USA, discusses his outlook for the Chinese brand's expansion into North America, and its strategy in expanding on lifestyle and apparel products, utilising collaborations and original IP. He says the company targets 20% in US store growth this year. He speaks exclusively with Haidi Stroud-Watts on "Bloomberg: The Asia Trade."
China's factory and non-manufacturing activity fared better than expected in June. BofA's Helen Qiao says the supply-side factors have been "pretty resilient for some time," but the "question is really on the demand-side - consumption and investment."
A new Lowy Institute survey points to a significant shift in Australians' views on China, the US alliance, and President Trump. Research Fellow Charles Lyons-Jones joins "Bloomberg: The Asia Trade" to unpack the results and their implications for Australia's strategic positioning in the Indo-Pacific.